Variation in Relative Risk of Venous Thromboembolism in Different Cancers

Thromb Haemost 2002; 87(06): 1076-1077
DOI: 10.1055/s-0037-1613136

Letters to the Editor

Schattauer GmbH

Authors

P. A. Thodiyil

¹Department of Surgical Oncology and Technology, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, London, United Kingdom
A. K. Kakkar

¹Department of Surgical Oncology and Technology, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, London, United Kingdom

References
1 Svendsen E, Karwinski B. Prevalence of pulmonary embolism at necropsy in patients with cancer. J Clin Pathol 1989; 42: 805-9.
2 Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-80.
3 Levitan N, Dowlati A, Remick SC, Tahasildar HI, Sivinski LD, Beyth R, Rimm AA. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine 1999; 78: 285-91.
4 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism. Arch Intern Med 1998; 158: 585-93.
5 Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.